Opin vísindi

Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data : A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice

Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data : A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice


Titill: Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data : A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice
Höfundur: Hogervorst, Milou A.
Soman, Kanaka V.
Gardarsdottir, Helga   orcid.org/0000-0001-5623-9684
Goettsch, Wim G.
Bloem, Lourens T.
Útgáfa: 2024
Tungumál: Enska
Umfang: 1849647
Birtist í: Value in Health; ()
ISSN: 1098-3015
DOI: 10.1016/j.jval.2024.08.002
Efnisorð: external controls; health technology assessment; indirect treatment comparisons; individual patient data; marketing authorization; real-world data; Health Policy; Public Health, Environmental and Occupational Health
URI: https://hdl.handle.net/20.500.11815/5068

Skoða fulla færslu

Tilvitnun:

Hogervorst , M A , Soman , K V , Gardarsdottir , H , Goettsch , W G & Bloem , L T 2024 , ' Analytical Methods for Comparing Uncontrolled Trials With External Controls From Real-World Data : A Systematic Literature Review and Comparison With European Regulatory and Health Technology Assessment Practice ' , Value in Health . https://doi.org/10.1016/j.jval.2024.08.002

Útdráttur:

Objectives: This study aimed to provide an overview of analytical methods in scientific literature for comparing uncontrolled medicine trials with external controls from individual patient data real-world data (IPD-RWD) and to compare these methods with recommendations made in guidelines from European regulatory and health technology assessment (HTA) organizations and with their evaluations described in assessment reports. Methods: A systematic literature review (until March 1, 2023) in PubMed and Connected Papers was performed to identify analytical methods for comparing uncontrolled trials with external controls from IPD-RWD. These methods were compared descriptively with methods recommended in method guidelines and encountered in assessment reports of the European Medicines Agency (2015-2020) and 4 European HTA organizations (2015-2023). Results: Thirty-four identified scientific articles described analytical methods for comparing uncontrolled trial data with IPD-RWD–based external controls. The various methods covered controlling for confounding and/or dependent censoring, correction for missing data, and analytical comparative modeling methods. Seven guidelines also focused on research design, RWD quality, and transparency aspects, and 4 of those recommended analytical methods for comparisons with IPD-RWD. The methods discussed in regulatory (n = 15) and HTA (n = 35) assessment reports were often based on aggregate data and lacked transparency owing to the few details provided. Conclusions: Literature and guidelines suggest a methodological approach to comparing uncontrolled trials with external controls from IPD-RWD similar to target trial emulation, using state-of-the-art methods. External controls supporting regulatory and HTA decision making were rarely in line with this approach. Twelve recommendations are proposed to improve the quality and acceptability of these methods.

Athugasemdir:

Publisher Copyright: © 2024

Skrár

Þetta verk birtist í eftirfarandi safni/söfnum: